CASE STUDY

Value & Access Organization Design

Building the right Value & Access structure for an innovative, clinical-stage biotech

Situation

The newly-appointed Global Head of Value & Access at an exciting clinical-stage biotech needed to design her organization, at the same time as leading value & access strategy for multiple products in late development, in rare and high-prevalence indications – including the company’s first ever launch.

Action

AESARA Strategy Consultants who have led as well as designed global and regional Value & Access (V&A) groups

  • Quickly established familiarity with the client biotech’s strategy and culture, through interviews with cross-functional executives

  • Tailored our deep industry experience into a benchmarking report
    • Selected comparator and contrastor company V&A org structures
    • Identified practical lessons specific to the client’s strategy, portfolio and maturity
  • Identified practical lessons specific to the client’s strategy, portfolio and maturity

  • Designed and iterated vison, mission, structure and resourcing, in close collaboration with client executive

Organization optimization

Region

Global

Client

Head of Value, Access and Policy

IMPACT

  • Delivered a bespoke and future-fit Value, Access & Policy organization
    • Focused on first-launch success
    • Scalable in line with company investment trajectory and inflection points
    • Innovatively designed and presented “market-inwards”, not routine “top-down”
  • Through sequential and careful touchpoints, used creative communications to bring C-suite executives on the journey, to approve the ultimate design and resource ask

Fit your need? Let us help.

US OFFICE

EUROPE OFFICE